Straumann today announced three important leadership changes to drive momentum in its two largest regions North America and Europe. The appointments, which have all been filled through internal development, become effective on 1 January 2016.
Having steered Straumann’s Western Europe region through economic recession and back to solid growth, Guillaume Daniellot will devote his drive, leadership skills and deep experience of the dental industry to capturing further growth opportunities in North America, which is still underpenetrated. Guillaume has been a member of Straumann’s Executive Management Board (EMB) and in his current position since 2013. He joined the company in 2007.
Over the past four years, Straumann’s organic revenue in North America has grown at an average of 8%, bringing the company closer to regional market leadership. A major contribution to this success has come from Executive Vice President Andy Molnar, who has headed the region since the beginning of 2012. Having been with the company for 10 years in senior leadership roles, Andy is considering a new career option at Straumann, which will be announced in due course.
Jens Dexheimer will step up to head the Western Europe region, which comprises the Nordics, the UK, Ireland, France, Benelux, Iberia and Italy. Jens will also join the Executive Management Board.
He has been with Straumann since 2010 and is currently responsible for the Group’s largest European market, Germany, which climbed back to solid growth in 2015. In his previous position as Head of Straumann Iberia, Jens brought the Straumann Iberian business effectively through the exceptional challenges of economic recession in Spain and Portugal, gaining share and adapting to the changing market conditions.
René Garo, current Head of Straumann Benelux will succeed Jens as Head of Straumann Germany. René has been with Straumann since 2007 and previously held the positions of General Manager Straumann Italy and Regional Finance Officer North America. His successor in the Benelux countries will be announced at a later date.
Headquartered in Basel, Switzerland, the Straumann Group (SIX: STMN) is a global leader in implant, restorative and regenerative dentistry. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Including its Neodent business, the Group currently employs approximately 3400 people worldwide and its products and services are available in more than 70 countries through its broad network of distribution subsidiaries and partners.